MACK - Merrimack Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 580.06M
Enterprise Value 323.65M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.36
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.39

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-39.03%
Return on Equity (ttm)-78.36%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -60.2M
Net Income Avi to Common (ttm)-60.77M
Diluted EPS (ttm)-3.04
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)71.28M
Total Cash Per Share (mrq)5.34
Total Debt (mrq)14.87M
Total Debt/Equity (mrq)25.29
Current Ratio (mrq)5.14
Book Value Per Share (mrq)4.41

Cash Flow Statement

Operating Cash Flow (ttm)-65.59M
Levered Free Cash Flow (ttm)-41.96M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.57
52-Week Change 3-28.45%
S&P500 52-Week Change 38.62%
52 Week High 310.53
52 Week Low 33.34
50-Day Moving Average 36.51
200-Day Moving Average 35.23

Share Statistics

Avg Vol (3 month) 378.57k
Avg Vol (10 day) 388.16k
Shares Outstanding 513.34M
Float 8.75M
% Held by Insiders 14.09%
% Held by Institutions 157.26%
Shares Short (Mar 29, 2019) 4304.4k
Short Ratio (Mar 29, 2019) 46.68
Short % of Float (Mar 29, 2019) 42.72%
Short % of Shares Outstanding (Mar 29, 2019) 42.28%
Shares Short (prior month Feb 28, 2019) 4334.15k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 310.55
Trailing Annual Dividend Yield 3175.54%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 26, 2017
Ex-Dividend Date 4May 30, 2017
Last Split Factor (new per old) 210/1
Last Split Date 3Sep 6, 2017